Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Top of the Hill
The cavalry is coming, for some

Posted 18 November

As data from the first Covid vaccines show they work, the expectation that a frontrunner will be approved in Australia around January and rolled out in March is looking increasingly realistic.

But what if the vaccines were for cancer and not for Covid? How would they fare then?

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Picking the path out of Covid
Now is not the time for leaders to play it safe
Special Report
Aust Covid Vaccine Tracker
UPDATE: Gilead hits back at WHO over remdesivir
Approvals Action
Trio of new drugs on ARTG
Roche, Seqirus, Clinuvel enlarge local portfolios